t

Argentina bondholders snub ‘disproportionate’ debt offer

Biggest creditors attack government’s proposal to restructure $65bn of foreign debt




t

Coronavirus gives Bolivia’s ‘interim’ president chance to extend rule

Jeanine Añez settles in for long haul as pandemic adds to political uncertainty




t

Brazil’s business leaders fret over Bolsonaro

Confidence levels plunge as growing political crisis compounds economic damage from coronavirus




t

Argentina ready to consider ninth sovereign default, says Guzmán

Finance minister tells FT that government has rejected counter-offer from BlackRock-led group of creditors




t

Venezuela says two US citizens detained in failed plot

Donald Trump denies Washington played role in alleged attempt to assassinate Maduro




t

The pandemic tests tempers and tolerance in Mexico

Some officials are using Covid-19 to jump on the neoliberal-bashing bandwagon




t

US captive in Venezuela says plan was to extract Maduro

Venezuela’s president airs video of former US soldier accused of taking part in thwarted plot




t

Cocaine trade caught in disrupted global supply chains

Drugs traffickers hit by coronavirus-induced slowdown and seizures, says UN agency




t

France limits nicotine sales after coronavirus study  

Stimulant given as ‘likely’ reason for lower infections but authorities stress health risks




t

FDA flags risks for virus drug promoted by Trump

US regulator cautions against using chloroquine outside of hospitals or clinical trials




t

Roche boss who says bitter pill of truth is only way to build trust  

Severin Schwan unapologetic for outspoken criticism of state responses to coronavirus




t

Lockdown eases, central banks, oil, pharma and tech earnings

Start every week on the front foot with a preview of what’s on the global agenda




t

US and Chinese researchers team up for hunt into Covid origins

Scientists co-operate on search for Covid-19 origins despite charges Beijing is withholding data




t

Drugmakers race to scale up vaccine capacity

Funding bodies face a choice between established manufacturers and biotech upstarts




t

Next’s Wolfson shows his workings for a new socially distant world

Boss of clothing retailer deserves a premium; Astra’s eyes on big prize




t

Fauci praises remdesivir after data show it speeds recovery

US-run trial of Gilead coronavirus therapy demonstrates ‘significant positive effect’




t

Remdesivir: Five things to know about the antiviral drug

Gilead’s potential coronavirus treatment stirs investor hopes but evidence on effectiveness is mixed




t

AstraZeneca and Oxford university agree deal to develop virus vaccine

Partnership that would prioritise UK could produce 100m doses by year-end if treatment is effective




t

Dozens of existing drugs being tested as possible virus treatments

Research paper published in journal Nature identifies number of alternative treatments




t

Coronavirus vaccine: an epidemic of nationalism

First country to get a vaccine could have an economic as well as a health advantage




t

Gilead hopes to produce 1m courses of remdesivir by year’s end

Biotech group’s shares have soared this year on hopes drug could be used to treat coronavirus




t

FDA gives emergency authorisation to remdesivir

US-led trial shows positive results in hastening recovery time for coronavirus patients




t

How an unproven drug became a bellwether for global stocks

Investors have bet on Gilead’s remdesivir as solution to coronavirus crisis




t

Cost of vaccinating billions against Covid-19 put at more than $20bn

Sum far exceeds $8bn fundraising target at upcoming EU-led donors’ conference




t

Can China win big in vaccine race with biotech bet

Nation’s pharma industry has matured but is still a lot better at incremental innovation than major breakthroughs




t

Coronavirus: US death toll approaches 62,000 — as it happened




t

Call to overhaul plasma rules to speed up potential virus therapy

Industry highlights bottlenecks in access to materials that are a possible Covid-19 treatment




t

FT Health: Combating Coronavirus

As researchers race to develop a coronavirus vaccine, we look at efforts to ensure that the world’s poor are not left behind — and ask whether the pandemic will jolt policymakers into confronting the looming threat from antimicrobial resistance




t

Coronavirus lessons for the fight against ‘superbugs’

The world needs to act now to avert the threat from antimicrobial resistance




t

Will poor countries get the treatments they need?

Pharma and its critics agree government has a big role to play in ensuring fair access to Covid-19 remedies




t

US regulator clears AbbVie’s $63bn deal for Allergan

Federal Trade Commission votes 3-2 to approve tie-up between makers of Botox and Humira




t

From blood clots to ‘Covid toe’: the medical mysteries of coronavirus

The wide variety of Covid-19 symptoms seen by doctors is confounding the scientific community




t

US solar industry powers ahead as investors back batteries

Fund managers and energy-hungry tech companies bankroll ‘solar-plus-storage’ projects




t

Hydrogen energy projects win £30m UK funding

Schemes to look at cutting emissions in sectors such as transport in push to meet 2050 ‘net zero’ target




t

PG&E posts $3.6bn quarterly loss after wildfire settlement

California utility discloses $5bn pre-tax charge tied to claims




t

Philippines: Duterte takes aim at the oligarchs

The president has turned his populist fire on big business, but is he attacking corporate greed or political opponents?




t

Global investors warn S Korea’s Kepco over carbon emissions

State-backed utility under pressure as it plans to invest in new coal mines




t

Trump appointees vote to block US coal joint venture

Shares in Peabody Energy and Arch Coal fall sharply after regulatory action




t

Drax to end use of coal at UK’s biggest power plant 3 years early

Group says 230 jobs will be lost at Selby site at it looks to beat 2025 fossil fuel deadline




t

The political debate on US energy is not connected to reality

American producers are coming under pressure on several fronts




t

Johnson revives onshore wind farms after 4-year ban

Policy reversal follows Cameron vow to rid UK of ‘unsightly’ structures




t

Coronavirus fears leave investors huddling in utilities

Demand for classically defensive stocks rises as viral outbreak worsens




t

China’s Belt and Road power grids keep security critics awake

As Beijing connects the region, the Philippines weighs ‘shutdown’ risk




t

Green boost as £800m pledged for carbon capture

Climate campaigners say measures lack ambition to tackle crisis




t

KKR to buy recycling group Viridor in £4.2bn deal

One of the first large acquisitions to be agreed since coronavirus pandemic rocked global markets




t

How emergency planning has kept lights on and taps running

Energy, water and other utility groups keep services going despite lockdowns and cuts




t

Britain’s electricity demand falls by a tenth in lockdown

Decline leads to a drop in wholesale prices as businesses close




t

Energy groups seek help on payment holidays

Loan scheme worth up to £100m a month would allow suppliers to assist struggling customers




t

Centrica suspends dividend as Ovo furloughs 3,400 workers

First signs of severity of coronavirus pandemic on UK energy sector 




t

Energy: how Texas learned to love solar power

A boom in projects across the Permian Basin comes amid coronavirus fears and a global oil price war